DENTSPLY SIRONA(XRAY) - 2024 Q2 - Quarterly Results

Q2 24 Summary Results (GAAP) • Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%) • GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02) • Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49 • Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10) • Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common ...